Page last updated: 2024-11-05

trifluoperazine and Cancer of Prostate

trifluoperazine has been researched along with Cancer of Prostate in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Whereas the treatment of prostate cancer cells individually with anti-CaM drug or calcimycin, which increases intracellular Ca(++) and activates Cpn, led to minimal AR breakdown, combined treatment led to a precipitous decrease in AR protein levels."1.37Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. ( Bai, VU; Barrack, ER; Chinnakannu, K; Kim, SH; Menon, M; Murthy, S; Reddy, GP; Sivanandam, A, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sivanandam, A1
Murthy, S1
Chinnakannu, K1
Bai, VU1
Kim, SH1
Barrack, ER1
Menon, M1
Reddy, GP1
Batra, S1
Popper, LD1
Hartley-Asp, B1

Other Studies

2 other studies available for trifluoperazine and Cancer of Prostate

ArticleYear
Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells.
    Journal of cellular physiology, 2011, Volume: 226, Issue:7

    Topics: Antineoplastic Agents; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin

2011
Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells.
    The Prostate, 1991, Volume: 19, Issue:4

    Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Calmodulin; Cell Divisio

1991